Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT

NCT05290545 PHASE3 COMPLETED

The objective of this study was to explore whether the combination with umbilical cord blood (UCB) is associated with superior disease-free survival (DFS) in the setting of haploidentical donors (HID) transplantation.

Details

Lead sponsor	Nanfang Hospital, Southern Medical University
Phase	PHASE3
Status	COMPLETED
Enrolment	314
Start date	Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Mar 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Hematological Malignancies
• Hematopoietic Stem Cell Transplantation

Interventions

• PBSCs
• Cord
• BMSCs

Countries

China